Who invested in TransformativeMed

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$7.0Mraised across 2 rounds since 2019, from 2 sources

$5.8MSeries A$1.2MVenture

Latest round: Venture, $1.2MMay 2022
Biggest round: $5.8MSeries A · May 2019
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202020212022

$5.8MSeries A$1.2MVenture

First round: Series A, $5.8M
Biggest round: $5.8M
Between rounds: 3 years

The rounds

May 2022
Venture$1.2M
No investor was named in the report.
Source recordedSEC filing: $1.2M sold, first sale Apr 2022
May 2019
Series A$5.8M1 new
- Alliance of Angels
Reported by Transformativemed

Founders and team

From TransformativeMed's own website and the SEC filings it signed: 1 founder, 3 on the team.

David StoneCo-Founder & Chief Executive OfficerNamed on its 2022 Form D

Isabella PaduaVP Business Operations
Erik Van EatonExecutive Officeri
Shawn DeWaneExecutive Officer, Directori

On the board, as filediDaniel RosenJoel MezistranoNathan Bays

Everyone who backed them

Alliance of AngelsAngel network1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list TransformativeMed as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.